- Home
- RGR vs KROS Comparison
RGR vs KROS Comparison
Compare RGR & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGR
- KROS
- Stock Information
- Founded
- RGR 1949
- KROS 2015
- Country
- RGR United States
- KROS United States
- Employees
- RGR N/A
- KROS N/A
- Industry
- RGR Ordnance And Accessories
- KROS Biotechnology: Pharmaceutical Preparations
- Sector
- RGR Industrials
- KROS Health Care
- Exchange
- RGR Nasdaq
- KROS Nasdaq
- Market Cap
- RGR 616.8M
- KROS 558.9M
- IPO Year
- RGR N/A
- KROS 2020
- Fundamental
- Price
- RGR $35.72
- KROS $14.53
- Analyst Decision
- RGR
- KROS Buy
- Analyst Count
- RGR 0
- KROS 13
- Target Price
- RGR N/A
- KROS $20.63
- AVG Volume (30 Days)
- RGR 191.8K
- KROS 477.3K
- Earning Date
- RGR 07-30-2025
- KROS 08-06-2025
- Dividend Yield
- RGR 1.96%
- KROS N/A
- EPS Growth
- RGR N/A
- KROS N/A
- EPS
- RGR 1.83
- KROS 0.11
- Revenue
- RGR $534,561,000.00
- KROS $214,713,000.00
- Revenue This Year
- RGR N/A
- KROS $5,006.76
- Revenue Next Year
- RGR $1.89
- KROS N/A
- P/E Ratio
- RGR $19.47
- KROS $132.80
- Revenue Growth
- RGR 0.65
- KROS 91657.70
- 52 Week Low
- RGR $32.74
- KROS $9.12
- 52 Week High
- RGR $46.40
- KROS $72.37
- Technical
- Relative Strength Index (RSI)
- RGR 41.91
- KROS 64.67
- Support Level
- RGR $35.53
- KROS $13.26
- Resistance Level
- RGR $36.36
- KROS $14.68
- Average True Range (ATR)
- RGR 0.70
- KROS 0.41
- MACD
- RGR -0.06
- KROS 0.12
- Stochastic Oscillator
- RGR 11.35
- KROS 89.35
About RGR Sturm Ruger & Company Inc.
Sturm Ruger & Co Inc and its subsidiary are principally engaged in the design, manufacture, and sale of firearms to domestic customers. The company's design and manufacturing operations are in the United States and almost all product content is domestic. The company has two reportable operating segments: firearms and castings. The firearms segment manufactures and sells rifles, pistols, and revolvers principally to a number of federally-licensed, independent wholesale distributors located in the United States. The castings segment manufactures and sells steel investment castings and metal injection molding parts. It generates maximum income from the sale of Firearms.
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.